(Q71625784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

The induction of p53 and WAF1/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

20 October 2019

main subject

1 reference

R B Gartenhaus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

P Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Hoffman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D Janson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

K R Rai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

143-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01575446

20 October 2019

exact match

0 references

cites work

Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis

1 reference

12 December 2020

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

1 reference

12 December 2020

WAF1, a potential mediator of p53 tumor suppression

1 reference

12 December 2020

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

1 reference

12 December 2020

Advances in the biology and treatment of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics

1 reference

12 December 2020

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

12 December 2020

Induction of WAF1/CIP1 by a p53-independent pathway

1 reference

12 December 2020

A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia

1 reference

12 December 2020

A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. The French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

12 December 2020

A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry.

1 reference

12 December 2020

Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway

1 reference

12 December 2020

Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine

1 reference

12 December 2020

Clinical staging of chronic lymphocytic leukemia

1 reference

12 December 2020

The treatment of chronic lymphocytic leukemia with COP chemotherapy

1 reference

12 December 2020

Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.

1 reference

12 December 2020

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

1 reference

12 December 2020

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

1 reference

12 December 2020

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

1 reference

12 December 2020

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

12 December 2020

Clinical Experience with Fludarabine in Leukaemia

1 reference

12 December 2020

p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01575446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8846164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference